Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Boost For Oral SERDs As Menarini/Radius’ Orserdu Becomes First Approved For Breast Cancer
Following US FDA Approval
Jan 30 2023
•
By
Ayisha Sharma
Menarini And Radius Have Won The Race For The First Oral SERD • Source: Shutterstock
More from New Products
More from Scrip